Not Always ROSY-Feasibility of Addressing Sexual Dysfunction in Women with Breast and Gynecologic Cancers with a Novel Mobile Application
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Sexual Dysfunction
- Sponsor
- The University of Texas Health Science Center, Houston
- Enrollment
- 20
- Locations
- 1
- Primary Endpoint
- Change in sex related personal distress as assessed by the Female Sexual Function Index (FSFI)
- Status
- Not yet recruiting
- Last Updated
- last year
Overview
Brief Summary
The purpose of this study is to identify breast and gynecologic cancer patients with sexual dysfunction, to measure sexual dysfunction with the Female Sexual Function Index (FSFI) and to provide Patients with the opportunity during this six-month period to follow up with a healthcare provider to discuss the sexual dysfunction needs and to see if a medical intervention can be of aid.
Investigators
Lavanya Palavalli Parsons
Assistant Professor
The University of Texas Health Science Center, Houston
Eligibility Criteria
Inclusion Criteria
- •Patient with a current or historic diagnosis of breast cancer or gynecologic cancer (uterine ovarian, fallopian tube, peritoneal, cervical, vulva, or vaginal cancers)
- •Agree to participate in the study with completion of survey and use of ROSY mobile application
Exclusion Criteria
- •Currently pregnant
- •Non-English speaking (ROSY is currently is only available is in English).
Outcomes
Primary Outcomes
Change in sex related personal distress as assessed by the Female Sexual Function Index (FSFI)
Time Frame: Baseline, 6 months
FSFI is a 19-item instrument that measures 6 domains of sexual function: Desire, Arousal, Lubrication, Orgasm, Satisfaction, and Pain. This uses a Likert-type scale, with scores ranging from 0 to 5, except for questions 1, 2, 13, and 16, which are scored from 1 to 5. The total score ranges from 2.0 to 36.0, with higher scores indicating better functioning.
Change in sexual dysfunction as assessed by the Social Determinants of Health (SDOH) questionnaire
Time Frame: Baseline, 6 months
score ranges from 0 to 10, higher score showing worse outcome
Secondary Outcomes
- Change in sex related personal distress as assessed by the Female Sexual Function Index (FSFI) in ethnic minority groups(end of study (6 months after baseline))
- Change in sex related personal distress as assessed by the Female Sexual Function Index (FSFI) in sexual and gender minority groups(end of study (6 months after baseline))
- Change in sex related personal distress as assessed by the Female Sexual Function Index (FSFI) in unpartnered women(end of study (6 months after baseline))